These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23004352)
1. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Imam MH; Shenoy PJ; Flowers CR; Phillips A; Lechowicz MJ Leuk Lymphoma; 2013 Apr; 54(4):752-9. PubMed ID: 23004352 [TBL] [Abstract][Full Text] [Related]
2. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype. Amber KT; Bloom R; Nouri K Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881 [TBL] [Abstract][Full Text] [Related]
3. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study. Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769 [TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003. Riou-Gotta MO; Fournier E; Mermet I; Pelletier F; Humbert P; Danzon A; Aubin F Leuk Lymphoma; 2008 Aug; 49(8):1537-44. PubMed ID: 18766967 [TBL] [Abstract][Full Text] [Related]
5. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Criscione VD; Weinstock MA Arch Dermatol; 2007 Jul; 143(7):854-9. PubMed ID: 17638728 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Bradford PT; Devesa SS; Anderson WF; Toro JR Blood; 2009 May; 113(21):5064-73. PubMed ID: 19279331 [TBL] [Abstract][Full Text] [Related]
7. Age, race, sex, stage, and incidence of cutaneous lymphoma. Wilson LD; Hinds GA; Yu JB Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):291-6. PubMed ID: 23040434 [TBL] [Abstract][Full Text] [Related]
8. Changing incidence trends of cutaneous T-cell lymphoma. Korgavkar K; Xiong M; Weinstock M JAMA Dermatol; 2013 Nov; 149(11):1295-9. PubMed ID: 24005876 [TBL] [Abstract][Full Text] [Related]
9. Incidence of primary cutaneous T-cell lymphoma in Norway. Saunes M; Nilsen TI; Johannesen TB Br J Dermatol; 2009 Feb; 160(2):376-9. PubMed ID: 18808419 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and severity of pruritus in cutaneous T cell lymphoma. Vij A; Duvic M Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy. Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286 [TBL] [Abstract][Full Text] [Related]
13. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541 [TBL] [Abstract][Full Text] [Related]
14. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study. Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395 [TBL] [Abstract][Full Text] [Related]
15. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases. Arai E; Katayama I; Ishihara K Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527 [TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970 [TBL] [Abstract][Full Text] [Related]
17. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822 [TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma. Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828 [TBL] [Abstract][Full Text] [Related]
19. Frequency of primary cutaneous lymphoma variants in Austria: retrospective data from a dermatology referral centre between 2006 and 2013. Eder J; Kern A; Moser J; Kitzwögerer M; Sedivy R; Trautinger F J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1517-23. PubMed ID: 25600184 [TBL] [Abstract][Full Text] [Related]
20. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma. Vidulich KA; Talpur R; Bassett RL; Duvic M Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]